← Back to Search

Cell Therapy

All Participants (within patient control) for Crush Injury

N/A

Waitlist Available

Research Sponsored by Avita Medical

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up prior to or at 8 weeks

Awards & highlights

Study Summary

This trial compares the performance of skin grafts with and without the RECELL system on acute non-burn full-thickness skin defects.

Eligible Conditions

Full Thickness Skin Grafts
Crush Injury
Flesh-Eating Disease
Surgical Wound
Cellulitis
Gunshot Injury
Infections
Degloving Injury
Skin Lacerations
Skin Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at weeks 26, 36 and 52

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at weeks 26, 36 and 52

This trial's timeline: 3 weeks for screening, Varies for treatment, and at weeks 26, 36 and 52 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Donor Skin Area to Treatment Area Expansion Ratio

Incidence of Treatment Area Healing

Other outcome measures

Investigator Treatment Preference

POSAS (Patient and Observer Scar Assessment Scale)

Subject Treatment Preference

Trial Design

1Treatment groups

Experimental Treatment

Group I: All Participants (within patient control)Experimental Treatment2 Interventions

Each participant will serve as their own Control, receiving both Control and Investigational Interventions randomly allocated to treatment of a portion of a full-thickness skin defect.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Investigational Intervention (RECELL + more widely meshed autograft)

2020

N/A

~70

Control Intervention (Conventional Autograft)

2020

N/A

~70

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Avita MedicalLead Sponsor

15 Previous Clinical Trials

585 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In how many sites is this clinical experiment being conducted?

"Currently, 20 medical centres across the USA are participating in this trial. Selecting a clinic near you when enrolling is advised to reduce travel time; locations include Chicago, Miami and Washington D.C., as well as other sites."

Answered by AI

Is the recruitment period for this experiment still taking place?

"According to the clinicaltrials.gov portal, this medical trial is currently not recruiting patients. Although initial data was posted on March 2nd 2020 and recently updated April 6th 2022, 916 other studies are actively seeking volunteers right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction

2020. "RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04091672.